undamentalytics Newsletter
Sign in

Guardant Health, Inc. income statement

In fiscal 2025, Guardant Health, Inc. reported revenue of $982m, up 32.9% on the year before, operating income of −$437m (a -44.5% margin) and net income of −$416m, or −$3.32 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2550912142873744505647399821,183
Cost of revenue———————227290349414
Gross profit———————337449633769
Research and development11265186150263374367348364376
Selling and marketing26325378107192300295365495630
General and administrative10373661193207164156180211234
Operating income−44−77−93−82−255−411−544−565−444−437−470
Interest expense33115333345
Income before tax−46−83−84−70−246−384−653−479−435−418−454
Income tax000−200111−1−1
Net income−46−83−85−76−254−385−655−479−436−416−453
Diluted EPS−$1.18−$2.36−$0.93−$0.84−$2.60−$4.00−$6.41−$4.28−$3.56−$3.32−$3.50
Diluted shares (average)39m38m91m91m98m101m102m112m123m125m129m
EBITDA−40−71−86−71−239−389−508−522−401−398−432

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: GH vs PNTGGH vs PGNYGH vs HQYGH vs INNV

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Guardant Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Guardant Health, Inc.